Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Youbang Fukang Pharmaceutical Research Institute is a specialized contract research organization (CRO) based in Jinan, China, that focuses on high-end pharmaceutical technology development. The institute provides comprehensive R&D services, including drug synthesis, formulation development, and quality control research, with a core expertise in generic drug consistency evaluation. It operates advanced laboratory facilities designed to support the entire drug development lifecycle from initial laboratory-scale research to pilot production and regulatory submission. The company serves as a strategic partner for pharmaceutical manufacturers, helping them navigate the complex regulatory requirements of the National Medical Products Administration (NMPA). By focusing on high-barrier generic drugs and innovative formulations, the institute plays a significant role in upgrading the quality standards of the domestic Chinese pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Youbang Fukang Medicine Institute.